Curevac N.V. Stock
Price
Target price
€2.14
€2.14
-8.660%
-0.204
-8.660%
€8.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Curevac N.V. Stock
Heavy losses for Curevac N.V. today as the stock fell by -€0.204 (-8.660%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Curevac N.V. stock is not clear.
Based on the current price of 2.14 € the target price of 8 € shows a potential of 273.83% for Curevac N.V. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Curevac N.V. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Curevac N.V. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
News
EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
EQS-News: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
EQS-News: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer